UK markets open in 2 hours 37 minutes

Myriad Genetics, Inc. (0K3W.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
17.32+0.02 (+0.14%)
At close: 02:37PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.79
52-week change 3-10.10%
S&P500 52-week change 317.24%
52-week high 324.13
52-week low 30.00
50-day moving average 321.46
200-day moving average 320.80

Share statistics

Avg vol (3-month) 3148
Avg vol (10-day) 3161
Shares outstanding 574.76M
Implied shares outstanding 6N/A
Float 873.39M
% held by insiders 12.22%
% held by institutions 1103.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023


Profit margin -35.51%
Operating margin (ttm)-25.67%

Management effectiveness

Return on assets (ttm)-9.35%
Return on equity (ttm)-29.50%

Income statement

Revenue (ttm)698.9M
Revenue per share (ttm)8.61
Quarterly revenue growth (yoy)2.30%
Gross profit (ttm)476.4M
EBITDA -119.9M
Net income avi to common (ttm)-248.2M
Diluted EPS (ttm)-0.11
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)121.6M
Total cash per share (mrq)1.49
Total debt (mrq)203.8M
Total debt/equity (mrq)27.72%
Current ratio (mrq)1.33
Book value per share (mrq)8.98

Cash flow statement

Operating cash flow (ttm)-44.2M
Levered free cash flow (ttm)-5.61M